
Dermoscopy, also known as dermatoscopy or epiluminescence microscopy, is a non-invasive, in vivo diagnostic technique that bridges the clinical and histopathological examination of skin lesions. By using a handheld device called a dermatoscope, which employs polarized or non-polarized light and fluid immersion to eliminate surface light reflection, it allows clinicians to visualize morphological features in the epidermis, dermo-epidermal junction, and the superficial dermis that are otherwise invisible to the naked eye. This tool has revolutionized the field of dermatology, significantly improving the diagnostic accuracy for both melanocytic and non-melanocytic skin tumors, reducing unnecessary excisions, and enabling earlier detection of malignancies. In the context of non-melanoma skin cancers, particularly basal cell carcinoma (BCC), dermoscopy provides a critical window into the lesion's architecture, guiding clinical decision-making.
Among the various subtypes of BCC, superficial basal cell carcinoma (sBCC) presents a unique diagnostic challenge. It is the second most common subtype, accounting for approximately 15-30% of all BCC cases in Caucasian populations. While data specific to Hong Kong is less prevalent due to differing skin phototypes and sun exposure patterns, a study from a major Hong Kong dermatology center indicated that BCC constitutes about 15-20% of all skin cancers locally, with the superficial subtype being less common than the nodular type but frequently encountered in clinical practice. sBCC typically presents as a slowly enlarging, erythematous, scaly patch or thin plaque, often mimicking benign inflammatory conditions like eczema or psoriasis, or other premalignant lesions such as actinic keratosis. Its superficial growth pattern, confined mostly to the epidermis and superficial dermis, means it lacks the classic pearly appearance and telangiectasias of nodular BCC, making clinical diagnosis based on inspection alone prone to error. This is where superficial bcc dermoscopy becomes indispensable, offering a detailed visual roadmap to identify specific features that confirm the diagnosis.
The dermoscopic diagnosis of sBCC relies on recognizing a constellation of specific features. Unlike melanocytic lesions assessed by pattern analysis, BCCs are evaluated based on the presence of discrete, well-defined structures. Mastery of these features is the cornerstone of accurate superficial bcc dermoscopy.
Arborizing (tree-like) telangiectasias are considered the hallmark dermoscopic feature of nodular BCC, characterized by thick, brightly red, sharply in-focus vessels that branch irregularly, resembling the branches of a tree. In sBCC, however, these vessels are often finer, shorter, and less prominent. They may appear as subtle, fine telangiectasias that are more focal rather than spanning the entire lesion. Sometimes, only a few short, fine arborizing branches are visible at the periphery. It is crucial to differentiate these from the comma vessels of dermal nevi or the polymorphous/atypical vessels of melanoma. The presence of even subtle arborizing vessels in a scaly patch should raise a high index of suspicion for sBCC, prompting a search for other corroborating features.
Leaf-like areas (also known as maple leaf-like structures) are among the most specific features for BCC, including the superficial subtype. Dermoscopically, they appear as brown to gray-blue, discrete, bulbous extensions connected to the periphery of the lesion by a short stalk, resembling a leaf or a bud. They represent compact aggregations of basaloid tumor cells with peripheral palisading. In sBCC, these structures are often multiple, small, and may be scattered throughout the lesion rather than clustered. Their color can vary from light brown to dark gray, and they are frequently found in association with other features like fine telangiectasias and ulceration. Recognizing these leaf-like structures is a powerful diagnostic clue in superficial bcc dermoscopy.
Ulceration is a common feature in BCCs due to the fragility of the tumor stroma and overlying epidermis. In sBCC, ulceration often presents differently than in nodular BCC. Instead of a large, central ulcer with a crust, sBCC may show multiple, small, superficial erosions or microulcerations. Dermoscopically, these appear as small, roundish, red or red-brown areas that lack a defined structure, often described as "red dots" or "red structureless areas." They may be scattered across the lesion and are frequently accompanied by subtle bleeding points or tiny, adherent hemorrhagic crusts. The presence of multiple small ulcerations in a scaly plaque is a strong indicator of sBCC and helps differentiate it from purely inflammatory conditions.
Fine blue-gray dots and globules (also known as multiple blue-gray globules or granules) are another highly suggestive feature of sBCC. These appear as numerous, small, ovoid, or roundish structures with a blue-gray hue, often described as resembling "pepper-like" granules. They are thought to correspond to small, dense aggregates of pigmented basaloid tumor cells or melanophages in the superficial dermis. In sBCC, they are typically numerous and evenly distributed or loosely clustered. They differ from the blue-white veil of melanoma, which is more confluent and structureless. The identification of these fine, peppery blue-gray globules within an erythematous patch significantly increases the diagnostic confidence for pigmented variants of sBCC.
Several other dermoscopic features can be observed in sBCC, though they may be less specific. These include:
Accurate diagnosis requires not only recognizing features of sBCC but also confidently distinguishing it from its clinical simulants. Dermoscopy provides the critical differentiating criteria.
Seborrheic keratosis (SK) is a common benign lesion that can appear as a scaly, stuck-on plaque, sometimes mimicking sBCC. Dermoscopically, SK is characterized by:
Actinic keratosis (AK), a precursor to squamous cell carcinoma, presents as a rough, scaly patch on sun-damaged skin, often indistinguishable from sBCC clinically. Dermoscopic features of AK include:
Bowen's disease (squamous cell carcinoma in situ) also presents as a slowly growing, scaly, erythematous plaque. Its dermoscopic features are more distinct:
Case 1: A 58-year-old man with Fitzpatrick skin type III presented with a 1.5 cm, slightly erythematous, scaly patch on his upper back of 8 months' duration. Clinically, it was considered a possible actinic keratosis or dermatitis. Dermoscopy revealed a background of faint erythema with several subtle, short, fine telangiectasias showing early branching. Scattered throughout were 4-5 small, brown-gray leaf-like structures. Furthermore, multiple tiny, red structureless areas (microulcerations) and a faint dusting of fine blue-gray globules were noted. No milia-like cysts or comedo-like openings were seen. The dermoscopic diagnosis was strongly suggestive of sBCC, which was confirmed by shave biopsy. This case highlights how superficial bcc dermoscopy can identify malignancy in a clinically ambiguous lesion.
Case 2: A 65-year-old woman from Hong Kong, with a history of chronic sun exposure, presented with a persistent, scaly plaque on her left shin. It had been treated as eczema with topical steroids with minimal response. Clinical examination showed a 2 cm, pink, scaly plaque. Dermoscopy under polarized light revealed prominent, shiny white-red structureless areas interspersed with multiple, small, focused erosions (ulcerations). Careful examination at the periphery showed a few fine, arborizing vessels. No glomerular vessels or strawberry pattern was present. Based on the combination of shiny white areas, microulcerations, and fine arborizing vessels, a diagnosis of sBCC was made and later confirmed histologically. This case underscores the utility of dermoscopy in evaluating treatment-resistant "eczematous" patches and the importance of searching for subtle vascular patterns.
The integration of dermoscopy into the clinical evaluation of suspicious skin lesions has unequivocally elevated the standard of care in dermatology. For superficial basal cell carcinoma, a lesion notorious for its benign mimics, dermoscopy serves as an indispensable diagnostic amplifier. It transforms a nondescript, scaly patch into a detailed landscape where specific features—short fine telangiectasias, leaf-like structures, microulcerations, and fine blue-gray globules—tell the story of malignancy. By systematically applying superficial bcc dermoscopy, clinicians can move beyond guesswork. It allows for a more confident diagnosis, facilitates early detection at a stage when less invasive treatments like topical therapy, photodynamic therapy, or superficial radiotherapy are highly effective, and reduces the number of benign lesions subjected to unnecessary surgical procedures. Ultimately, proficiency in dermoscopic recognition of sBCC and its differentials is not just an academic skill but a practical tool that enhances patient outcomes, optimizes healthcare resources, and solidifies the dermatologist's role as an expert in skin cancer diagnosis and management. Continuous education and hands-on practice are essential to maintain and improve this diagnostic acumen.